Loading
Earnings sentiment for Drug Manufacturers - General — aggregated from 9 earnings calls in the Healthcare sector
As of 2026 Q1, the Tellvest aggregate earnings-call sentiment for the Drug Manufacturers - General industry is 6.9/10 across 9 companies.
Aggregated from 9 earnings calls
A composite score derived from averaging overall earnings sentiment across all analyzed companies in this industry for their latest reported quarter. Score is 0–10 (10 = most positive).
Average sentiment across the group rose from 6.78 to 6.89. Seven names moved. Five gained a point, ABBV (8 to 9), GILD (7 to 8), LLY (9 to 10), PFE (4 to 5), and BIIB (3 to 4), while the two largest anchors to move eased two points each, JNJ (9 to 7) and BMY (6 to 4). Pricing pressure as a shared theme eased from 7 companies to 5, while cost pressure rose from 3 to 4.
| Signal | Companies | Direction breakdown |
|---|---|---|
| AI & Tech | 4 | 4 |
| FX | 4 | 211 |
| Regulation Policy | 4 | 121 |
| Consumer Demand | 3 | 111 |
% change over the trailing year, log scale. 1Y and YTD are each name’s own price return. Equal-weight: average of every full-history member, weighted equally, not rebalanced.